You have no items in your shopping cart.
On Promotion
Category
Tested Applications
Reactivity
Predicted Reactivity
Conjugation
Biologically Active
Featured Product
Search results for: 'antigen'
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 37.9 KDa. Observed: 50-75 KDa, reducing conditions
Cynomolgus
Glu31Arg369
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 74.5 KDa. Observed: 90-120 KDa, reducing conditions
Human
Gln22-His458
C-Fc
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 80.3 KDa. Observed: 110-160 KDa, reducing conditions
Human
Val22-Met503
C-Fc
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 37.09 KDa. Observed: 38-50 KDa, reducing conditions
Human
Ser20-Gly347
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 42.2 KDa. Observed: 45-60 KDa, reducing conditions
Mouse
Phe94 - Val232
N-Fc
50 μg, 500 μg, 1 mg, 10 μgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 42.1 KDa. Observed: 45-65 KDa, reducing conditions
Human
Ala29-Asp159
C-Fc
10 μg, 50 μg, 1 mg, 500 μgBiotin
SDS-PAGE: Greater than 90% as determined by reducing SDS-PAGE.. SEC-HPLC: Greater than 90% as determined by SEC-HPLC.(QC verified)
Predicted: 55.3 KDa. Observed: 58-75 KDa, reducing conditions
Human
Phe20-Thr263
C-Fc-Avi
20 μg, 100 μgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 42 KDa. Observed: 50-65 KDa, reducing conditions
Mouse
Val26-Asp158
C-Fc
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 38.1 KDa. Observed: 45-60 KDa, reducing conditions
Human
Glu31-Arg370
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 11.13 KDa. Observed: 18 KDa, reducing conditions
Human
Asp23-Asp122
C-6His
10 μg, 50 μg, 500 μg, 1 mg